Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. The company's products include Regalia, a plant extract-based fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants. It also provides Zequanox, a biomolluscicide that controls invasive mussels, which cause infrastructure and ecological damage primarily to power and industrial companies; and Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes. In addition, the company offers Haven, an anti-transpirant plant health product that reduces plant stress and dehydration; and Majestene, a bionematicide to control soil-dwelling nematodes by preventing and reducing root galls, as well as reducing adult reproduction and egg hatch. Marrone Bio Innovations, Inc. provides its products directly, as well as through distributors. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was founded in 2006 and is headquartered in Davis, California.
Industry, Sector and Symbol
Industry Agricultural chemicals
Sub-IndustryN/A
SectorBasic Materials
SymbolNASDAQ:MBII
CUSIPN/A
Phone530-750-2800
Debt
Debt-to-Equity Ratio-1.23%
Current Ratio0.87%
Quick Ratio0.42%
Price-To-Earnings
Trailing P/E Ratio-1.58
Forward P/E Ratio-12.21
P/E GrowthN/A
Sales & Book Value
Annual Sales$18.17 million
Price / Sales9.61
Cash FlowN/A
Price / CashN/A
Book Value($1.62) per share
Price / Book-1.06
Profitability
EPS (Most Recent Fiscal Year)($1.07)
Net Income$-30,920,000.00
Net Margins-172.11%
Return on EquityN/A
Return on Assets-75.74%
Miscellaneous
Employees103
Outstanding Shares102,090,000
